13F-HR filed by Pivotal bioVenture Partners Investment Advisor LLC
Pivotal bioVenture Partners Investment Advisor LLC filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-13, with 12 holding rows worth $161,342,907.
- Accession
- 0001012975-25-000438
- Filer
- CIK 1844645
- Filed
- 2025-08-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 12 entries on the cover page, a total value of $161,342,907 stated on the cover page (in dollars after the unit check, H1), rows summing to $161,342,907 with VALUE read as dollars as filed, 13F file number 028-20630. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerPivotal bioVenture Partners Fund I U.G.P. Ltd028-20631
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| OCULIS HOLDING AG | H5870P102 | CMN | 2,300,774 | $44,658,023 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 1,305,125 | $42,429,614 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 2,120,508 | $29,729,522 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 4,494,851 | $17,979,404 | dollars as filed | |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 779,045 | $7,548,946 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 1,146,110 | $6,269,222 | dollars as filed | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 560,595 | $4,456,730 | dollars as filed | |
| RECURSION PHARMACEUTICALS IN | 75629V104 | CL A | 595,518 | $3,013,321 | dollars as filed | |
| BIOAGE LABS INC COM | 09077V100 | Stock | 653,374 | $2,698,435 | dollars as filed | |
| IO BIOTECH INC | 449778109 | COM | 864,197 | $1,201,234 | dollars as filed | |
| RALLYBIO CORP | 75120L100 | COM | 2,404,644 | $812,770 | dollars as filed | |
| BOLT BIOTHERAPEUTICS INC | 097702203 | COM NEW | 94,573 | $545,686 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001012975-25-000438 | this filing | 2025-08-13 | acceptance time not in the bulk data set |